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RT-PCRMethods: Retrospectively, the authors enrolled laboratory-confirmed adult dengue patients
from July 2008 to January 2012 in a tertiary hospital. The sensitivities of each test alone
and in combination were analyzed by the duration of illness (early stage: day 0-day 3 and late
stage: day 4-day 8). The factors influencing sensitivity of the Dengue NS1 Ag STRIP were exam-
ined.
Results: There were 392 patients enrolled. The overall sensitivity of the Dengue NS1 Ag STRIP
was 68.37% and PCR was 71.94%. With the assistance of the Dengue NS1 Ag STRIP, a diagnosis
was made in 10.97% of patients without the need for second convalescent samples, and 4.34%
more cases were detected. Independent factors for reduced Dengue NS1 Ag STRIP sensitivity
were dengue virus (DENV) IgG seropositivity and a sample taken after the fifth day of illness.
At the early stage, the PCR and the Dengue NS1 Ag STRIP combination had the highest sensi-
tivity rate than other combinations. At the late stage, a combination of the Dengue NS1 Ag
STRIP and capture IgM/IgG ELISA had better sensitivity rates. PCR and capture IgM/IgG ELISA
in combination had sensitivity above 90% through the course of illness.
Conclusion: Dengue NS1 Ag STRIP is a useful tool for early dengue diagnosis. Its use can
increase the diagnostic sensitivity and decrease the need of convalescent samples. Seeking
treatment late (days postonset > 4) and DENV IgG seropositivity independently decrease the
sensitivity of the Dengue NS1 Ag STRIP.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Approximately 50 million people are infected by dengue
annually and approximately 2.5 billion people live in
dengue-endemic countries. The diagnosis of acute dengue
infection is important for patient care and outbreak
control. In recent years, the geographic distribution of
dengue has expanded and the incidence has increased
rapidly.1,2 Dengue outbreaks have occurred in Taiwan
almost every year since 1987.3 All four dengue virus (DENV)
serotypes were present in recent outbreaks in Taiwan,4 and
the occurrence of dengue cases was not limited in southern
Taiwan. To constrain dengue outbreak, the faster the
diagnosis, the better for the patient and outbreak control
measures.
Nonstructural protein 1 (NS1) is a glycoprotein secreted
by DENV infected mammalian cells.5 Because the soluble
form of NS1 can be detected in the bloodstream, tests such
as antigen-capture enzyme-linked immunosorbent assay
(ELISA), lateral flow antigen detection, and measurement
of NS1-specific immunoglobulin (Ig)M and IgG responses
have been developed.5
Dengue is a notifiable infectious disease in Taiwan, and
patients suspected to have dengue should be notified within
24 hours.3 The sera are sent to reference laboratories and
are tested by real-time reverse-transcription polymerase
chain reaction (RT-PCR), capture IgM/IgG ELISA, and virus
isolation.3 Since August 2008, the Dengue NS1 Ag STRIP (Bio-
Rad Laboratories, Marnes-la-Coquette, France), an immu-
nochromatographic test (ICT), has been used as one of the
diagnostic tools for outbreak surveillance.6,7 This test has
proven useful for on-site detection of imported cases at
Taiwan airports and it allows early detection of dengue
cases.8 However, the benefit of adding Dengue NS1 Ag STRIP
has not yet been investigated among nationwide trans-
mission control in Taiwan.
We conducted a hospital-based retrospective study to
compare the dengue diagnostic tests routinely used inTaiwan. The usefulness of the Dengue NS1 Ag STRIP and
factors influencing its sensitivity were also evaluated.
Materials and methods
Study design and patients
Adult patients (age 18 years or older) with laboratory-
confirmed dengue presenting to Kaohsiung Medical Univer-
sity Hospital (KMUH) during July 2008 to January 2012 were
enrolled. KMUH is a 1700-bed tertiary referral center in
southern Taiwan but also provides primary health care.
Patient information and clinical data from medical
records were reviewed under the approval of the KMUH
institutional review board. The diagnosis sheet provided by
the Taiwan Centers for Disease Control (Taiwan CDC)
includes results of real-time RT-PCR and serotype, if
available, as well as Dengue NS1 Ag STRIP and capture IgM
and IgG ELISA. If the result in a single serum sample is
undetermined, a second sample is requested for capture
IgM/IgG ELISA during the convalescent phase to make the
final diagnosis. To compare the diagnostics used in outbreak
surveillance, only records with a single sample tested by all
three methods (RT-PCR, NS1 rapid test, and capture IgM/
IgG ELISA) were enrolled in our analysis.
Definition
Day 0 indicates the day of symptom onset.9 We analyzed
patients who received diagnostic tests during the period of
day 0 to day 8 of illness. To evaluate the influence of
duration of illness at the time of sample collection on
sensitivity of diagnostics, day 0 to day 3 is defined as the
early stage of illness and day 4 to day 8 as the late stage.
We compared demographic characteristics and sensitivity
of diagnostics by stratum of duration of symptoms (0e3
days vs. 4e8 days). To investigate the factors influencing
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fifth day of illness onset as delayed detection phase (day 5
to day 8). A previous study found the sensitivity of NS1
declined obviously after the fifth day of illness.10 The
elderly are defined as age 65 years or older.Dengue diagnosis
The reporting system for dengue in Taiwan was described in
a previous study.3 The routine diagnotic tools included real-
time RT-PCR, Dengue NS1 Ag STRIP, capture IgM and IgG
ELISA, and virus isolation.3,11,12 According to the guidelines
for dengue control in Taiwan, all methods are used before
the eighth day of illness.4 A confirmed dengue case is defined
as a single sample that tests positive by RT-PCR, virus
isolation, or Dengue NS1 Ag STRIP. Paired serology (samples
collected in acute and convalescent phase) revealing four-
fold increase or seroconversion of dengue virusespecific IgM
or IgG is also defined as a confirmed case.4 The result of virus
isolation was not included for analysis, because it took more
than 1 week to obtain a result and therefore was less
applicable for early diagnosis. We use the terms PCR, NS1,
IgM, and IgG to mean real-time RT-PCR, Dengue NS1 Ag
STRIP, and capture IgM and IgG ELISA, respectively.Figure 1. (A) Serotype distribution during 2008 to 2011.
(B) Age distribution of dengue cases. aOne case was notified in
January 2012.Statistical analysis
Pearson chi-square and Fisher exact test were used for
categorical variables. Continuous variables between groups
were compared using the Wilcoxon rank-sum test. The
logistic regression was performed to identify independent
determinants. The sensitivity of diagnostics was calculated
as [(positive cases tested)/(confirmed cases tested)] 100%.
All statistical analyses were performed using JMP software,
version 9.0.0 (SAS Institute Inc. Cary, NC, USA). Significance
was assigned at p < 0.05 for all parameters and all analyses
were two-tailed.Results
Characteristics of the study population
During the study period, 888 suspected dengue cases were
notified and 471 people had laboratory-confirmed dengue
at KMUH. Among these, 442 (93.84%) were adults, and 392
patients were tested with all three diagnostic methods
within 9 days postonset (DPO) of illness (day 0 to day 8) and
were enrolled for analysis. From years 2008 to 2011, the
numbers of cases in each year were 15, 48, 171, and 158,
and the dominant serotypes (DENV) were DENV1, DENV3,
DENV3, and DENV2, respectively (Fig. 1A). The number of
dengue patients peaked in the 50- to 54-year age group
(13.52%), whereas the elderly (age 65 years and older)
accounted for 16.33% of the total cases (Fig. 1B). The
median age was 48 years (quartile 32e58.75), and females
comprised 55.36% of all cases (Table 1). There was no
difference in age, sex, or incidence of underlying diseases
by stage of illness (0e3 days and 4e8 days). DENV2 and
DENV3 were predominant serotypes during the study periodbased on PCR results, but patients with unknown serotype
accounted for 29.34% of cases (Table 1).
Sensitivity of diagnostics
The overall sensitivities of PCR, NS1, and capture IgM/IgG
ELISA were 71.94%, 68.37%, and 40.05%, respectively. The
capture IgM/IgG ELISA had higher sensitivity at the late
stage (10.05% vs. 74.32%, p < 0.0001) (Table 2). The PCR
and NS1 double positive rate was 53.06% and the difference
between the early and late stages was significant (68.9% vs.
34.97%, p < 0.0001) (Table 2).
Among the three combinations of any two diagnostic
methods, the combination of PCR and capture IgM/IgG ELISA
had the best sensitivity at both stages. The combination of
PCR and NS1 had a sensitivity of 99.52% (only one case
missed) at the early stage; however, the sensitivity dropped
to 73.22% at the late stage (p < 0.0001). In contrast, the
sensitivity was better at the late stage (96.17%) than the
early stage (78.95%) when NS1 and capture IgM/IgG ELISA
were combined to make a diagnosis (p < 0.0001) (Table 2).
The sensitivity of these diagnostic tests and any two in
combination by illness day are shown in Fig. 2.
Role of PCR
In approximately 13% of patients, diagnosis was made by PCR
solely and most of them were at the early stage (PCRþ/
Table 1 Comparison of demographic characteristics and dengue serotypes of 392 patients in early and late stage of dengue
infection
Variable Stages Total cases (n Z 392)
n (%)Days 0e3 (n Z 209)
n (%)
Days 4e8 (n Z 183)
n (%)
p
Median agea 48 (32e59.5) 48 (33e58) 0.9309 48 (32e58.75)
Sex
Male 95 (45.45) 80 (43.72) 0.7297 175 (44.64)
Female 114 (54.55) 103 (56.28) 217 (55.36)
Diabetes mellitus 33 (15.79) 32 (17.49) 0.6522 65 (16.58)
Hypertension 40 (19.14) 38 (20.77) 0.6874 78 (19.90)
Chronic kidney diseaseb 13 (6.25) 6 (3.28) 0.1727 19 (4.86)
Hepatitis B and/or C 28 (13.40) 15 (8.20) 0.1002 43 (10.97)
Serotype
DENV1 5 4 9 (2.30)
DENV2 117 39 156 (39.80)
DENV3 73 38 111 (28.32)
DENV4 0 1 1 (0.26)
Unknown 14 101 115 (29.34)
a Quartile in parentheses.
b At the early stage, one patient did not have renal function data.
DENV Z dengue virus.
NS1 antigen rapid test in dengue outbreak surveillance 361serology/NS1, early stage vs. late stage: 21.05% vs. 3.83%,
p< 0.0001) (Table 2). Age older than 65 years, hepatitis B/C,
and early stage (days 0e3) were factors associated with
isolated PCR positivity in univariate analysis (p Z 0.0082,
0.0385, and< 0.0001, respectively) (Table 3). Age older than
65 years and sample collected at the early stage were inde-
pendent factors in multivariate analysis (adjusted odds ratio
[OR]: 2.421, 6.407, respectively) (Table 3).Table 2 Sensitivities of diagnostics and laboratory results of co
stage
Variable S
Days 0e3 (n Z 209)
n (%)
Da
n (
PCR sensitivity 196 (93.78) 8
NS1 sensitivity 156 (74.64) 11
IgM/IgG (þ) 21 (10.05) 13
Both RT-PCR and NS1 positive 144 (68.9) 6
PCR and/or NS1 positive 208 (99.52) 13
PCR and/or IgM/IgG positive 200 (95.69) 17
NS1 and/or IgM positive 158 (75.6) 16
NS1 and/or IgM/IgG positive 165 (78.95) 17
PCR (þ), IgM/IgG (þ), NS1 (þ) 9 (4.31) 3
PCR (þ), IgM/IgG (e), NS1 (þ) 135 (64.59) 3
PCR (þ), IgM/IgG (þ), NS1 (e) 8 (3.83) 1
PCR (þ), IgM/IgG (e), NS1 (e) 44 (21.05)
PCR (e), IgM/IgG (þ), NS1 (þ) 3 (1.44) 4
PCR (e), IgM/IgG (e), NS1 (þ) 9 (4.31)
PCR (e), IgM/IgG (þ), NS1 (e) 1 (0.48) 4
a Fisher exact test.
IgGZ immunoglobulin G; IgMZ immunoglobulin M; NS1Z Dengue NS
transcriptase-polymerase chain reaction.Role of NS1
Without NS1, we may miss the diagnosis in approximately
4% of patients at both early and late stages (PCR/
serology/NS1þ, 4.31% vs. 4.37%, p Z 0.9747). A second
sample would be needed for capture IgM/IgG ELISA for
approximately one-tenth of patients (10.97%) to make
a definite diagnosis, particularly when patients presentednfirmed cases, the results were compared by early and late
tages Total cases (n Z 392)
n (%)ys 4e8 (n Z 183)
%)
p
6 (46.99) <0.0001 282 (71.94)
2 (61.2) 0.0043 268 (68.37)
6 (74.32) <0.0001 157 (40.05)
4 (34.97) <0.0001 208 (53.06)
4 (73.22) <0.0001a 342 (87.24)
5 (95.63) 0.9747 375 (95.66)
5 (90.13) 0.0002 323 (82.40)
6 (96.17) <0.0001 341 (86.99)
2 (17.49) <0.0001 41 (10.46)
2 (17.49) <0.0001 167 (42.60)
5 (8.2) 0.0663 23 (5.87)
7 (3.83) <0.0001 51 (13.01)
0 (21.86) <0.0001a 43 (10.97)
8 (4.37) 0.9747 17 (4.34)
9 (26.78) <0.0001a 50 (12.76)
1 Ag STRIP; PCRZ polymerase chain reaction; RT-PCRZ reverse
Figure 2. Sensitivities of Dengue NS1 Ag STRIP (NS1), poly-
merase chain reaction (PCR), and immunoglobulin M/immu-
noglobulin G (IgM/IgG) and their combination. DPO Z days
postonset.
362 C.-H. Huang et al.at the late stage (PCR/serologyþ/NS1þ, 1.44 vs. 21.86%,
p < 0.0001) (Table 2).
Sensitivity of NS1 related to serotypes
The sensitivity of NS1 was different between DENV2 and
DENV3 significantly (65.38% vs. 88.78%, p Z 0.0008). When
we compared the NS1 sensitivity between DENV2 and
DENV3 by days of illness, the difference was only significant
on day 2 (65.71% vs. 89.29%, p Z 0.0385) and on day 3 was
borderline significant (64.1% vs. 87.1%, pZ 0.0522) (Fig. 3).
Sensitivity of NS1 related to IgM/IgG status and PCR
results
There was a significant difference in NS1 sensitivity
between the IgG-positive and -negative patients (28.57% vs.
75.99%, p < 0.0001). This difference was also observed in
DENV IgM status (IgMþ vs. IgM: 58.65% vs. 73.36%,
p Z 0.003). However, when we added the effect of DENV
IgG, the effect of DENV IgM on the NS1 sensitivity reduction
disappeared (IgMþ/IgG vs. IgM/IgG: 70.21% vs. 78.30%,
p Z 0.1209). The sensitivity of NS1 was lower in patientsTable 3 Factors influencing PCR positivity, with negative result
Variable Univariate analysis
Crude odds
ratios
Lower
95% CI
Upper
95% CI
Age 65 y and older 2.483 1.238 4.805
Diabetes mellitus 1.091 0.475 2.275
Hypertension 1.453 0.709 2.821
Chronic kidney diseasea 1.844 0.509 5.336
Hepatitis B and/or C 2.276 1.001 4.825
Sample in early stage 6.705 3.122 16.667
a One patient did not have renal function data.
b Adjustment for age, sex, hepatitis B and/or C, and stage in multi
CI Z confidence interval; ELISA Z enzyme-linked immunosorbe
NS1 Z Dengue NS1 Ag STRIP.with PCR-negative results than in those with positive results
(54.55% vs. 73.76%, p Z 0.0005).
Factors influencing the sensitivity of NS1
The univariate analyses for factors influencing the sensi-
tivity of NS1 revealed that older age (55 years and older vs.
18e34 years old, OR: 2.23 [95% CI: 1.43e3.48],
p Z 0.0004), delayed detection (days 5e8 vs. days 0e4,
OR: 2.50 [95% CI: 1.60e3.92], p < 0.0001), DENV IgG sero-
positivity (OR: 7.91 [95% CI: 4.40e14.76], p < 0.0001), and
patients with diabetes mellitus (OR: 1.82 [95% CI:
1.05e3.14], pZ 0.0313) or hypertension (OR: 2.35 [95% CI:
1.41e3.92], p Z 0.001) are more likely to associate with
negative results. In multivariate analysis, delayed detec-
tion (days 5e8 vs. days 0e4, adjusted OR: 1.93 [95% CI:
1.16e3.20], p Z 0.0105) and DENV IgG seropositivity
(adjusted OR: 6.07 [95% CI: 3.24e11.72], p < 0.0001) were
independently associated with negative NS1 results in
dengue patients (Table 4).
Discussion
Our results reveal NS1 to be a useful tool for early dengue
diagnosis. For patients who are DENV IgG seropositive and
seekingtreatment late (DPO > 4), the results of NS1 need to
be judged carefully. The results are more likely to be
negative in these patients despite dengue virus infection.
In the current study, the sensitivity of NS1 was 68.37%,
which was lower than in a previous study in Taiwan that
used the test for imported case detection.8 In that study,
most of the samples were taken early (DPO < 5) (19 of 22,
86.36% vs. 68.11% in the current study), and the DENV2
percentage was lower than ours (3 of 22, 13.64% vs.
39.80%). In previous reports, the sensitivity and specificity
of NS1 were between 61.6-90.4% and 94.4-100%, respec-
tively.9 Unlike other reports using stored sera or plasma to
evaluate the sensitivity of diagnostics,7,9,13e18 samples in
the current study had been tested within 24 hours after
being collected for outbreak surveillance. We believe our
results better reflect real-world practice.
Osorio et al9 found the factors influencing the reduced
sensitivity of NS1-based diagnostic tools included sampless in both NS1 and capture IgM/IgG ELISA (n Z 392)
Multivariate analysis
p Adjusted
odds ratiosb
Lower
95% CI
Upper
95% CI
p
0.0082 2.421 1.168 4.875 0.0147
0.8264
0.2856
0.2947
0.0385 2.111 0.897 4.678 0.0735
<0.0001 6.407 2.960 16.017 <0.0001
variate logistic regression.
nt assay; IgM/IgG Z immunoglobulin M/immunoglobulin G;
Figure 3. Sensitivity of Dengue NS1 Ag STRIP by dengue virus
(DENV) 2 and 3.
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secondary infections, and those with DENV2 and 4. We had
similar findings, but the influence of duration of illness at
the time of sample collection was delayed to the fifth day.
In our study, the sensitivity on the fifth day (DPO 4) was still
higher (75.89%) than average, and in the multivariate
logistic regression analysis, delayed detection (day 5eday 8)
was an independent factor for negative NS1 results.
During our study period, the predominant serotypes were
DENV2 and 3. There was a significant difference in NS1
sensitivity between these two serotypes. The IgM/IgG
ratio was not provided on the CDC diagnostic sheet;
therefore, we could not distinguish primary from
secondary infection. However, a patient with secondary
infection is more likely to have DENV IgG detected duringTable 4 Logistic regression to determine the risk of Dengue NS
Variable Univariate analysis
Crude
odds ratios
Lower
95% CI
Upper
95% CI
Age
Age group 1 (18e34 y) 1
Age group 2 (35e54 y) 0.815 0.522 1.263
Age group 3 (55 y) 2.230 1.432 3.479
Detected phase
Early phase (days 0e4) 1
Delayed phase (days 5e8) 2.502 1.600 3.923
IgG seropositive 7.911 4.401 14.764
Underlying diseases
Diabetes mellitus 1.821 1.049 3.136
Hypertension 2.355 1.414 3.919
Chronic kidney diseasea 2.011 0.780 5.120
Hepatitis B and/or C 1.479 0.759 2.819
a One patient did not have renal function data.
b Adjustment for age, sex, detected phase, DENV IgG seropositivity,
chronic kidney disease and hepatitis B and/or C in multivariate logist
CI Z confidence interval; DENV Z dengue virus; IgG Z immunoglobuacute dengue virus infection. DENV IgG seropositivity was
an independent factor for a negative NS1 result in
patients infected with dengue virus in our study.
To the best of our knowledge, this is the first study to
investigate the influence of underlying diseases and age on
the sensitivity of commercial NS1 antigen tests. In univar-
iate analyses, older patients, patients with diabetes mel-
litus, and those with hypertension were more likely to test
negative, but these factors were not independent in
multivariate analysis. We suggest that PCR/capture IgM/IgG
ELISA for dengue diagnosis would be beneficial in these
patients.
The existence of DENV IgG appeared to decrease the
sensitivity of NS1. A hypothesis has been proposed that the
kinetics between NS1-specific IgG and DENV IgG are
similar.7 The reduced NS1 sensitivity is due to NS1 antigen
binding to NS1-specific IgG to form immune complexes.7The
existence of DENV IgM also had a similar effect on the
sensitivity of NS1 in the current study. However, there was
no difference in NS1 sensitivity between IgMþ/IgG and
IgM/IgG patients. One report found this reduction of
sensitivity influenced by DENV IgM was observed in the
commercial NS1 ELISA test (Platelia, Bio-Rad) but not in the
NS1 ICT.14 Another study found the NS1 sensitivity in IgMþ/
IgG patients was significantly higher than in IgM/IgG 
patients in another NS1 ICT test (SD Dengue Duo, Standard
Diagnostics).19 Further study designed to explore the real
effect of DENV IgM is needed.
In PCR-positive patients, the sensitivity of NS1 was
significantly higher than in PCR-negative patients. Other
studies found NS1-positive patients had higher viremia
levels,14,19 which explained the relationship between NS1
sensitivity and PCR results.
With the assistance of NS1, approximately 4% more cases
were detected with single samples at either the early or1 Ag STRIP being negative (n Z 392)
Multivariate analysis
p Adjusted
odds ratiosb
Lower
95% CI
Upper
95% CI
p
0.3632 1.296 0.698 2.445 0.4159
0.0004 1.973 0.977 4.020 0.0588
<0.0001 1.932 1.163 3.199 0.0105
<0.0001 6.069 3.243 11.716 <0.0001
0.0313 0.863 0.413 1.761 0.6907
0.001 1.487 0.722 3.040 0.2778
0.1396 1.576 0.520 4.627 0.4099
0.2398 1.624 0.771 3.341 0.1925
and underlying disease including diabetes mellitus, hypertension,
ic regression.
lin G.
364 C.-H. Huang et al.late stage. At the late stage, the diagnosis of dengue can be
made in more than 20% of the patients without the need for
a second sample in the convalescent phase. This result
showed NS1 can help us implement environment and vector
control early in an outbreak. The NS1 detected more than
50% of patients with PCR-negative samples, and this rate
was higher than in a previous report (37%).20 This may be
due to more of our patients having the blood test at the late
stage than the previous report (46.68% vs. 34.3%) and to the
sensitivity of PCR dropping earlier than that of NS1.
The overall sensitivity of PCR was 71.94%, and the
sensitivity started to decrease after day 3. This finding is
similar to that of a previous study.15 We would have missed
the diagnosis in one-fifth (21.05%) of patients visiting within
the first 4 days of illness if PCR was not used. Using PCR, we
can detect dengue in more patients at the early stage, and
control measures can be taken earlier. We also found that
in the elderly (age 65 years and older) and patients pre-
senting at the early stage, a diagnosis might be more likely
with PCR.
In a previous study, the combination of Platelia Dengue
NS1 Ag (Bio-Rad ELISA) and IgM (MAC-ELISA) detected 82% of
cases in samples collected in the first 4 days of illness
onset.21 Our finding (NS1 and/or IgM positive: 82.4%) was
consistent with this observation. When IgG was added, the
sensitivity increased to 87% (NS1 and/or IgM and/or IgG
positive). Of note, at the early stage the sensitivity of
either combination (NS1/IgM and NS1/IgM/IgG) was below
80%, which means we may miss the diagnosis in more than
20% of patients if we use these two diagnostic combinations
at the early stage.
The combination of PCR and NS1 for a single sample
could detect most cases in the first 4 days (99.52%), but the
sensitivity decreased at the late stage. The best strategy
would be to combine PCR and capture IgM/IgG ELISA
because the sensitivity was higher than 95% whether at the
early or late stage. Because of the cost and the require-
ments for laboratory facilities and trained personnel, the
PCR-based diagnostic strategy may not be a good choice in
resource-limited regions.
There are some limitations in our study. First, we did not
use the clinical symptoms and signs in our diagnostics
analysis, which would be important especially for
a resource-poor area. Although low specificity, the sensi-
tivity of the World Health Organization (WHO) 1997 classi-
fication to define illness is 95.4% and approximately 80%
when WHO 2009 classification is applied.15 Second, in our
study, the serotype was determined only by PCR and there
were 29.34% of the patients having unknown serotype;
therefore, we could not analyze the exact effect of sero-
types on the sensitivity of NS1. Third, we used DENV IgG
detection to represent secondary infection and this could
not give us the real proportions of primary and secondary
infections. This is more similar in a real-world scenario,
because clinicians read capture IgM/IgG ELISA results
without knowing whether they arise from a primary or
secondary infection. Fourth, we could not calculate the
specificity of NS1. When NS1 was positive, the second
sample would be not requested. The possibility of false-
positive results with NS1 might exist. According to
a previous report,9 the specificity of NS1 is approximately
100% and in our study, patients notified were clinicallysuspected dengue cases. We believe the false-positive rate
is extremely low.
In conclusion, the Dengue NS1 Ag STRIP played an
important role in the early diagnosis of acute dengue
infection. However, it might be used with caution in
patients with secondary DENV infection or serum samples
being taken after the fifth day of illness. The sensitivity of
Dengue NS1 Ag STRIP would be compromised under these
circumstances.
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